- Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting. Dutoit, V., Taub, R.N., Papadopoulos, K.P., Talbot, S., Keohan, M.L., Brehm, M., Gnjatic, S., Harris, P.E., Bisikirska, B., Guillaume, P., Cerottini, J.C., Hesdorffer, C.S., Old, L.J., Valmori, D. J. Clin. Invest. (2002)